DCF — SHARP CHULA VISTA MEDICAL CENTER
Enterprise Value: $-794.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-794.2M
Enterprise Value
$-252.5M
PV of Cash Flows
$-541.7M
PV of Terminal Value
$-872.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $534.6M | $-48.8M | -9.0% | $-71.4M | $-64.9M |
| Year 2 | $550.7M | $-44.7M | -8.0% | $-68.1M | $-56.2M |
| Year 3 | $567.2M | $-40.4M | -7.0% | $-64.4M | $-48.4M |
| Year 4 | $584.2M | $-38.7M | -7.0% | $-63.4M | $-43.3M |
| Year 5 | $601.7M | $-38.4M | -6.0% | $-63.8M | $-39.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-794.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$519.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.09625715043346218
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5